Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-065700
Filing Date
2010-03-24
Accepted
2010-03-24 15:58:52
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 956817
2 CONSENT OF KPMG dex231.htm EX-23.1 1879
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9468
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9468
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2972
6 SECTION 906 CFO CERTIFICAITON dex322.htm EX-32.2 3040
  Complete submission text file 0001193125-10-065700.txt   985265
Mailing Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021
Business Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

EIN.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-20897 | Film No.: 10701848
SIC: 2834 Pharmaceutical Preparations